The drug safety information in domestic medical literature

Author:

Ochyra Bartlomiej1ORCID,Szewczyk Maciej2,Przybylkowski Adam1ORCID

Affiliation:

1. Department of Gastroenterology and Internal Diseases , Medical University of Warsaw , Warsaw , Poland

2. MS Pharm s.r.o. , Praga , Czech Republic

Abstract

Abstract Medical literature is an important source of drug safety information relevant for signal detection, safety profile analysis and risk-benefit assessment. The main goal of our study was to assess the utility of domestic medical literature as a source of drug safety information. All safety information identified for active substances published between 1.01.2018-31.12.2019 in domestic medical journals published in Poland were analyzed. Four thousand seven hundred eighty-nine drug safety information was reported for 500 active substances. Two thousand and forty-four submissions dealing with drug safety (48.28%) were identified in the 10 journals from the list of analyzed journals (3 of these were identified in the 2019 JCR and 5 of these were indexed in the main scientific databases and 9 of these had an affiliation to scientific society). There was a correlation between journal impact factor and scientific database indexation with the number of published individual literature reports and type of safety information. Journals publishing in Polish constituted source for about 40% of all safety information published in the examined period. Journals indexed in Medline were the source of about 37% of all safety information while 42% was published in Embase. Local medical literature is a source of valuable safety information but the list of journals for monitoring should be carefully selected with particular attention to journals with impact factor.

Publisher

Walter de Gruyter GmbH

Subject

Pharmacology,Molecular Biology,General Medicine,Biochemistry

Reference11 articles.

1. 1. European Medicines Agency (EMA). Guideline on good pharmacovigilance practices (GVP) Module VI – Collection, management and submission of reports of suspected adverse reactions to medicinal products (Rev 2). 2017.

2. 2. Rymarczuk A, Bielski M, Lozak K, Ochyra B, Szewczyk M, Miernecka D, et al) Dobór czasopism medycznych wydawanych w Polsce dla celów przeglądów lokalnej literaratury medycznej w zakresie bezpieczeństwa stosowania produktów leczniczych. – Standard Polskiego Towarzystwa Bezpiecznej Farmakoterapii (PTBFarm). Biuletyn Bezpieczenstwa Produktow Leczniczych. 2020;15(1).

3. 3. Ferguson J, Mockbee C, Erbele S, Muniz E. Evaluation of Published Case Reports’ Standards and Notification. Drug Inforn l. 2002;36:303-7.10.1177/009286150203600208

4. 4. Hauben D, Aronson J. Gold Standards in Pharmacovigilance. Drug Safety. 2007;30:645-55.10.2165/00002018-200730080-0000117696577

5. 5. Impicciatore P, Mucci M. Completeness of published case reports on suspected adverse drug reactions: evaluation of 100 reports from a company safety database. Drug Saf. 2010;33(9):765-73.10.2165/11537500-000000000-0000020701409

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3